Executive Leadership

Chad Croasdale plays a pivotal role in executing Evergen’s commercial vision as the CDMO of choice in regenerative medicine solutions.

Prior to joining Evergen, Chad served as President and Chief Commercial Officer of 270 Surgical, a product development, branding, product positioning, commercial strategy, and business development company. Chad also held leadership roles at Stryker, where he spent 18 years in roles of increasing responsibility in sales and marketing before serving as VP and General Manager of Stryker Communications, Endoscopy. 

Chad earned a Master of Science in Physical Therapy from Widener University and a Bachelor of Arts in Psychology from Hobart College.